4-Hydroxyderricin Promotes Apoptosis and Cell Cycle Arrest through Regulating PI3K/AKT/mTOR Pathway in Hepatocellular

Xiang Gao1, Yuhuan Jiang1, Qi Xu1

  • 1Institute of Biomedical Engineering, College of Life Sciences, Qingdao University, Qingdao 266071, China.

Foods (Basel, Switzerland)
|September 28, 2021
PubMed

Insights

4-hydroxyderricin (4-HD), a natural compound from Angelica keiskei, inhibits liver cancer cells by inducing apoptosis and cell cycle arrest. It suppresses the PI3K/AKT/mTOR pathway, offering a potential therapeutic strategy for hepatocellular carcinoma (HCC).

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Hepatocellular carcinoma (HCC) is a major global health concern with limited effective treatments.
  • Natural compounds are being explored for their anti-cancer properties.
  • The inhibitory mechanisms of 4-hydroxyderricin (4-HD) from Angelica keiskei on liver cancer remain largely unelucidated.

Purpose of the Study:

  • To investigate the inhibitory effects of 4-hydroxyderricin (4-HD) on hepatocellular carcinoma (HCC) cells.
  • To clarify the mechanisms underlying 4-HD's anti-cancer activity, focusing on apoptosis and cell cycle regulation.
  • To explore the role of the PI3K/AKT/mTOR signaling pathway in 4-HD-mediated effects.

Main Methods:

  • Cell viability and activity assays were performed on HepG2 and Huh7 HCC cell lines.
  • Western blot analysis was used to assess protein expression levels of apoptosis-related and cell cycle-related genes.
  • The expression of key proteins in the PI3K/AKT/mTOR pathway (PI3K, p-PI3K, p-AKT, p-mTOR) was quantified.
  • The effect of a PI3K inhibitor (LY294002) in combination with 4-HD was evaluated.

Main Results:

  • 4-hydroxyderricin (4-HD) significantly reduced the survival rate and activity of HepG2 and Huh7 cells.
  • 4-HD treatment led to increased expression of apoptosis-related proteins and decreased expression of cell cycle-related proteins.
  • 4-HD down-regulated the protein expression of PI3K, p-PI3K, p-AKT, and p-mTOR.
  • Co-administration of 4-HD with a PI3K inhibitor (LY294002) potentiated apoptosis and cell cycle arrest in HCC cells.

Conclusions:

  • 4-hydroxyderricin (4-HD) exhibits significant inhibitory effects on hepatocellular carcinoma (HCC) cell proliferation.
  • 4-HD suppresses HCC progression by inducing apoptosis and cell cycle arrest.
  • The anti-cancer effects of 4-HD are mediated through the modulation of the PI3K/AKT/mTOR signaling pathway.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.1K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.8K